Well after weeks and weeks of waiting my order got completed last week at 11c

Very illiquid stock. No trades were done on 11 Nov despite the huge rally in the ASX200 especially the tech sector.

The only reason I can find that explains this is that it is too small to be on an institutions radar.

Or maybe this area of medtech is too crowded with bigger players such as Phillips at the top of the chain as I mentioned earlier.

I'm surprised by this considering this stock is near the top of the Strawman list of companies.

Having said that, if the company can hit their targets maybe all those issues can be ignored.